BRIEF-Shionogi: Execution Of Sub-License Agreement From Ping An-Shionogi Hong Kong To Juniper Therapeutics And SAR Approval In Singapore Regarding Ensitrelvir Fumaric Acid For Covid-19
Dec 19 (Reuters) - Shionogi & Co Ltd:
* SHIONOGI: EXECUTION OF SUB-LICENSE AGREEMENT FROM PING AN-SHIONOGI HONG KONG TO JUNIPER THERAPEUTICS AND SAR APPROVAL IN SINGAPORE REGARDING ENSITRELVIR FUMARIC ACID FOR COVID-19 Source text for Eikon: Further company coverage: (Reporting by Rocky Swift)